Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Kabadi SM"" wg kryterium: Autor


Wyświetlanie 1-8 z 8
Tytuł:
Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
Autorzy:
Koshiol J; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA.
Yu B; Oncology Biometrics, AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA.
Kabadi SM; Medical Affairs Epidemiology and Real-World Evidence, AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA.
Baria K; Global Medical Affairs, AstraZeneca Pharmaceuticals, Gaithersburg, MD, USA.
Shroff RT; Division of Hematology and Oncology, University of Arizona Cancer Center, 1515 N. Campbell Ave, PO Box 245024, Tucson, AZ, 85724-5024, USA. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2022 Nov 16; Vol. 22 (1), pp. 1178. Date of Electronic Publication: 2022 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Biliary Tract Neoplasms*/epidemiology
Cholangiocarcinoma*/epidemiology
Cholangiocarcinoma*/therapy
Gallbladder Neoplasms*/epidemiology
Bile Duct Neoplasms*/epidemiology
Bile Duct Neoplasms*/therapy
United States/epidemiology ; Humans ; Bile Ducts, Intrahepatic
Czasopismo naukowe
Tytuł:
Real-world evidence on survival, adverse events, and health care burden in Medicare patients with mantle cell lymphoma.
Autorzy:
Goyal RK; Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA.
Jain P; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
Nagar SP; Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA.
Le H; US HEOR Oncology, AstraZeneca, Gaithersburg, MD, USA.
Kabadi SM; Epidemiology and Real-World Evidence in Oncology, AstraZeneca, Gaithersburg, MD, USA.
Davis K; Department of Health Economics, RTI Health Solutions, Research Triangle Park, NC, USA.
Kaye JA; Department of Epidemiology, RTI Health Solutions, Waltham, MA, USA.
Du XL; The University of Texas Health Science Center at Houston, Houston, TX, USA.
Wang M; Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX, USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2021 Jun; Vol. 62 (6), pp. 1325-1334. Date of Electronic Publication: 2021 May 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Lymphoma, Mantle-Cell*/drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Bendamustine Hydrochloride/therapeutic use ; Cyclophosphamide/therapeutic use ; Delivery of Health Care ; Doxorubicin/therapeutic use ; Humans ; Medicare ; Prednisone/therapeutic use ; Retrospective Studies ; Rituximab/adverse effects ; United States/epidemiology ; Vincristine/therapeutic use
Czasopismo naukowe
Tytuł:
Overall survival, adverse events, and economic burden in patients with chronic lymphocytic leukemia receiving systemic therapy: Real-world evidence from the medicare population.
Autorzy:
Goyal RK; RTI Health Solutions, Research Triangle Park, NC, USA.
Nagar SP; RTI Health Solutions, Research Triangle Park, NC, USA.
Kabadi SM; AstraZeneca, Gaithersburg, MD, USA.
Le H; AstraZeneca, Gaithersburg, MD, USA.
Davis KL; RTI Health Solutions, Research Triangle Park, NC, USA.
Kaye JA; RTI Health Solutions, Waltham, MA, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2021 Apr; Vol. 10 (8), pp. 2690-2702. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Lymphocytic, Chronic, B-Cell/*drug therapy
Leukemia, Lymphocytic, Chronic, B-Cell/*economics
Leukemia, Lymphocytic, Chronic, B-Cell/*mortality
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/economics ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cost of Illness ; Drug Costs ; Female ; Health Care Costs ; Humans ; Male ; Medicare ; Middle Aged ; Retrospective Studies ; United States
Czasopismo naukowe
Tytuł:
Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis.
Autorzy:
Epperla N; Division of Hematology, The James Cancer Hospital and Solove Research Institute, The Ohio State University Comprehensive Cancer Center, A346 Starling Loving Hall, 320W 10th Ave, Columbus, OH, 43210, USA. .
Pavilack M; AstraZeneca, Gaithersburg, MD, USA.
Olufade T; AstraZeneca, Gaithersburg, MD, USA.
Bashyal R; STATinMED Research, Plano, TX, USA.
Li J; STATinMED Research, Plano, TX, USA.
Kabadi SM; AstraZeneca, Gaithersburg, MD, USA.
Yuce H; New York City College of Technology, New York, NY, USA.
Andritsos L; Division of Hematology and Oncology, The University of New Mexico, Albuquerque, NM, USA.
Pokaż więcej
Źródło:
Orphanet journal of rare diseases [Orphanet J Rare Dis] 2020 Feb 13; Vol. 15 (1), pp. 47. Date of Electronic Publication: 2020 Feb 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Leukemia, Hairy Cell*/drug therapy
Adolescent ; Adult ; Cost of Illness ; Health Care Costs ; Humans ; Insurance Claim Review ; Middle Aged ; Nucleosides ; Purine Nucleosides ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Treatment patterns, adverse events, healthcare resource use and costs among commercially insured patients with mantle cell lymphoma in the United States.
Autorzy:
Kabadi SM; AstraZeneca, Gaithersburg, MD, USA.
Near A; IQVIA, Falls Church, VA, USA.
Wada K; IQVIA, Falls Church, VA, USA.
Burudpakdee C; IQVIA, Falls Church, VA, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Dec; Vol. 8 (17), pp. 7174-7185. Date of Electronic Publication: 2019 Oct 08.
Typ publikacji:
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms:
Cost of Illness*
Antineoplastic Combined Chemotherapy Protocols/*adverse effects
Drug-Related Side Effects and Adverse Reactions/*economics
Health Care Costs/*statistics & numerical data
Lymphoma, Mantle-Cell/*drug therapy
Adenine/analogs & derivatives ; Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/economics ; Cyclophosphamide/administration & dosage ; Cyclophosphamide/adverse effects ; Cyclophosphamide/economics ; Doxorubicin/administration & dosage ; Doxorubicin/adverse effects ; Doxorubicin/economics ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/etiology ; Female ; Follow-Up Studies ; Health Care Rationing/economics ; Health Care Rationing/statistics & numerical data ; Hospitalization/economics ; Hospitalization/statistics & numerical data ; Humans ; Incidence ; Insurance, Health/economics ; Insurance, Health/statistics & numerical data ; Lymphoma, Mantle-Cell/economics ; Male ; Middle Aged ; Piperidines ; Practice Patterns, Physicians'/economics ; Practice Patterns, Physicians'/statistics & numerical data ; Prednisone/administration & dosage ; Prednisone/adverse effects ; Prednisone/economics ; Pyrazoles/administration & dosage ; Pyrazoles/adverse effects ; Pyrazoles/economics ; Pyrimidines/administration & dosage ; Pyrimidines/adverse effects ; Pyrimidines/economics ; Retrospective Studies ; Rituximab/administration & dosage ; Rituximab/adverse effects ; Rituximab/economics ; Treatment Outcome ; United States/epidemiology ; Vincristine/administration & dosage ; Vincristine/adverse effects ; Vincristine/economics ; Young Adult
Czasopismo naukowe
Tytuł:
Treatment patterns, adverse events, and economic burden in a privately insured population of patients with chronic lymphocytic leukemia in the United States.
Autorzy:
Kabadi SM; AstraZeneca, Gaithersburg, Maryland.
Goyal RK; RTI Health Solutions, Research Triangle Park, North Carolina.
Nagar SP; RTI Health Solutions, Research Triangle Park, North Carolina.
Kaye JA; RTI Health Solutions, Waltham, Massachusetts.
Davis KL; RTI Health Solutions, Research Triangle Park, North Carolina.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2019 Jul; Vol. 8 (8), pp. 3803-3810. Date of Electronic Publication: 2019 May 29.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cost of Illness*
Insurance Coverage*
Practice Patterns, Physicians'*
Leukemia, Lymphocytic, Chronic, B-Cell/*epidemiology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Disease Management ; Female ; Health Care Costs ; Humans ; Insurance, Health ; Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis ; Leukemia, Lymphocytic, Chronic, B-Cell/mortality ; Leukemia, Lymphocytic, Chronic, B-Cell/therapy ; Male ; Middle Aged ; Patient Selection ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States.
Autorzy:
Goyal RK; a RTI Health Solutions , Research Triangle Park , NC , USA.
Nagar SP; a RTI Health Solutions , Research Triangle Park , NC , USA.
Kabadi SM; b AstraZeneca , Gaithersburg , MD , USA.
Kaye JA; c RTI Health Solutions , Waltham , MA , USA.
Seal B; b AstraZeneca , Gaithersburg , MD , USA.
Mato AR; d Department of Medicine, Division of Hematological Malignancies , Memorial Sloan Kettering Cancer Center , New York , NY , USA.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Apr; Vol. 60 (4), pp. 955-963. Date of Electronic Publication: 2018 Oct 02.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cost of Illness*
Health Resources*
Insurance, Health*
Lymphoma, Mantle-Cell/*epidemiology
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Comorbidity ; Female ; Humans ; Lymphoma, Mantle-Cell/diagnosis ; Lymphoma, Mantle-Cell/therapy ; Male ; Middle Aged ; Practice Patterns, Physicians' ; Proportional Hazards Models ; Public Health Surveillance ; Risk Factors ; United States/epidemiology ; Young Adult
Czasopismo naukowe
Tytuł:
Multivariate path analysis of serum 25-hydroxyvitamin D concentration, inflammation, and risk of type 2 diabetes mellitus.
Autorzy:
Kabadi SM; Department of Epidemiology and Biostatistics, Drexel University School of Public Health, 1505 Race Street, Bellet Building 6th Floor, Philadelphia, PA 19102, USA.
Liu L
Auchincloss AH
Zakeri IF
Pokaż więcej
Źródło:
Disease markers [Dis Markers] 2013; Vol. 35 (3), pp. 187-93. Date of Electronic Publication: 2013 Aug 19.
Typ publikacji:
Journal Article
MeSH Terms:
Diabetes Mellitus, Type 2/*blood
Vitamin D/*analogs & derivatives
Adult ; Aged ; Diabetes Mellitus, Type 2/diagnosis ; Diabetes Mellitus, Type 2/epidemiology ; Disease Susceptibility ; Female ; Glycated Hemoglobin/analysis ; Humans ; Male ; Middle Aged ; Multivariate Analysis ; Sex Factors ; Vitamin D/blood
Czasopismo naukowe
    Wyświetlanie 1-8 z 8

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies